A Potential Method for Enhanced Performance of Nimodipine by Spanlastic Nanovesicle with Tween 40 as Edge Activator

Authors

  • Hussein K. Alkufi Department of Pharmacognosy, College of Pharmacy, University of Thi-Qar, 64001, Iraq
  • Hanan J. Kassab Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq

DOI:

https://doi.org/10.31351/vol34iss2pp227-238

Keywords:

spanlastic nanovesicle , edge activator , non-ionic surfactant , Nimodipine , study design , soluplus

Abstract

This investigation aimed to investigate the potential of utilizing nanospanlastics to improve the bioavailability of nimodipine (NMD). To treat subarachnoid hemorrhage-induced vasospasm, physicians prescribe NMD, an FDA-approved drug. Intravenous (IV) administration is the most common way to provide NM, and it can have several unfavorable effects, including injection site irritation, bradycardia, hypotension, and arrhythmias. Made up of surfactants and edge activators (EAs), nanospanlastics are malleable nanovesicles. EAs improve the deformability of spanlastics by acting as a stabilizing force on their vesicular membranes. To make NMD-loaded spanlastics, ethanol was injected according to a 23 factorial design. This was done to see how different factors affected particle size, PDI, and entrapment efficiency (EE%). Stability investigations, FESEM, FTIR, DSC, and in vitro characterization were performed on the optimized formula. The optimized formula (F19) demonstrated a notable improvement in EE% and stability, as well as longer drug release. Nanospanlastics not only made NMD much more soluble and bioavailable, but it also made it a more appealing nanoplatform for hydrophobic drug delivery.

How to Cite

1.
Hussein K. Alkufi, kassab hanan. A Potential Method for Enhanced Performance of Nimodipine by Spanlastic Nanovesicle with Tween 40 as Edge Activator. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Jun. 25 [cited 2025 Jun. 26];34(2):227-38. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3828

Publication Dates

Received

2024-06-27

Accepted

2024-10-23

Published Online First

2025-06-25

References

Feigin VL, Rinkel GJE, Lawes CMM, Algra A, Bennett DA, van Gijn J, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36(12):2773–80.

Ghareeb MM, Neamah AJ. Formulation and characterization of nimodipine nanoemulsion as ampoule for oral route. Int J Pharm Sci Res. 2017;8(2):591.

Al-Jehani H, Angle M, Marcoux J, Teitelbaum J. Early abnormal transient hyperemic response test can predict delayed ischemic neurologic deficit in subarachnoid hemorrhage. Crit Ultrasound J. 2018 Jan;10(1):1-6.

Alhagiesa AW, Ghareeb MM. Formulation and evaluation of nimodipine nanoparticles incorporated within orodispersible tablets. Int J Drug Deliv Technol. 2020;10(4):547–52.

Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, et al. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Colloids Surf B Biointerfaces. 2013 Sep;109:161–6.

Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces. 2012;97:109–16.

Basalious EB, Shamma RN. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies. Int J Pharm. 2015;493(1–2):347–56.

Li H, Li H, Wei C, Ke J, Li J, Xu L, et al. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2018;117:321–30.

Moreno LCGEAI, Solas M, Martínez-Ohárriz MC, Muñoz E, Santos-Magalhães NS, Ramirez MJ, et al. Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice. Int J Pharm. 2018;543(1–2):245–56.

Badria F, Mazyed E. Formulation of Nanospanlastics as a Promising Approach for ‎Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-‎Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro ‎Characterization, and ex vivo Permeation Study. Drug Des Devel Ther. 2020;14:3697–721.

Al-Mahallawi AM, Khowessah OM, Shoukri RA. Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies. Int J Pharm. 2017;522(1–2):157–64.

Zheng W, Fang X, Wang L, Zhang Y. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 2012;436(1–2):291–8.

Pandey M, Choudhury H, Gorain B, Tiong SQ, Wong GYS, Chan KX, et al. Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting. Gels (Basel, Switzerland). 2021 Nov;7(4) 218. https://doi.org/10.3390/gels7040218

Alhammid SNA, Kassab HJ, Hussein LS, Haiss MA. Spanlastics Nanovesicles: An Emerging and Innovative Approach for Drug Delivery. Maaen J Med Sci. 2023;2(2) 100-107.

Abdelrahman FE, Elsayed I, Gad MK, Elshafeey AH, Mohamed MI. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 2017;530(1–2):1–11.

Rashid AM, Abdal-Hammid SN. Formulation and characterization of itraconazole as nanosuspension dosage form for enhancement of solubility. Iraqi J Pharm Sci. 2019;28(2):124–33.

Ghareeb MM. Formulation and characterization of isradipine as oral nanoemulsion. Iraqi J Pharm Sci. 2020;29(1):143–53.

Salih OS, Al-Akkam EJ. Preparation, In-vitro, and Ex-vivo Evaluation of Ondansetron Loaded Invasomes for Transdermal Delivery. Iraqi Journal of Pharmaceutical Sciences. 2023 Dec 30;32(3):71-84.

Jakubowska E, Milanowski B, Lulek J. A systematic approach to the development of cilostazol nanosuspension by liquid antisolvent precipitation (LASP) and its combination with ultrasound. Int J Mol Sci. 2021;22(22):12406.

Guan T, Miao Y, Xu L, Yang S, Wang J, He H, et al. Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics. Int J Pharm. 2011;410(1–2):180–7.

Gorajana A, Rajendran A, Rao NK. Preperation and in vitro evaluation of solid dispersions of nimodipine using PEG 4000 and PVP K30. Asian Journal of Pharmaceutical Research and Health Care. 2010;2(2):163-9.

Wolska E, Szymańska M. Comparison of the In Vitro Drug Release Methods for the Selection of Test Conditions to Characterize Solid Lipid Microparticles. Pharmaceutics. 2023; 3;15(2):511.

Corrigan OI, Timoney RF. Towards standardizing agitation conditions in the beaker dissolution method. International Journal of Pharmaceutics. 1978 ; 1;1(5):299-302.

Alhagiesa AW, Ghareeb MM. The Formulation and Characterization of Nimodipine Nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi J Pharm Sci. 2021;30(2):143–52.

Chen XT, Wang T. Preparation and characterization of atrazine-loaded biodegradable PLGA nanospheres. Journal of Integrative Agriculture. 2019; 1;18(5):1035-41.

Praveen A, Aqil M, Imam SS, Ahad A, Moolakkadath T, Ahmad FJ. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study. Colloids Surf B Biointerfaces. 2019;174:553–62.

Jassem NA, Abd Alhammid SN. Enhancement of the Dissolution and Solubility of Canagliflozin Using Nanodispersion Systems. Al-Rafidain J Med Sci. 2024;6(1):222–31.

Muhammed SA, Al-Kinani KK. Formulation and in vitro evaluation of meloxicam as a self-microemulsifying drug delivery system. F1000Res. 2023 May 30;12:315. doi: 10.12688/f1000research.130749.2.

Ugorji OL, Okoye OI, Nwangwu C, Agbo CP, Kenechukwu FC. Soluplus-stabilized 5-fluorouracil-entrapped niosomal formulations prepared via active and passive loading techniques: comparative physico-chemical evaluation. Journal of Dispersion Science and Technology. 2024;45(5):891-9.

Kenechukwu FC, Kalu CF, Momoh MA, Onah IA, Attama AA, Okore VC. Novel Bos indicus fat-based nanoparticulate lipospheres of miconazole nitrate as enhanced mucoadhesive therapy for oral candidiasis. Biointerface Res Appl Chem. 2022;13(1):24.

Havrdova M, Polakova K, Skopalik J, Vujtek M, Mokdad A, Homolkova M, Tucek J, Nebesarova J, Zboril R. Field emission scanning electron microscopy (FE-SEM) as an approach for nanoparticle detection inside cells. Micron. 2014; 1;67:149-54.

Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res. 2016;5(1):48.

Kang JH, Kim YJ, Yang MS, Shin DH, Kim DW, Park IY, Park CW. Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in Rats. Pharmaceutics. 2021; 19;13(9):1519. doi: 10.3390/pharmaceutics13091519.

Kassab HJ, Alkufi HK, Hussein LS. Use of factorial design in formulation and evaluation of intrarectal in situ gel of sumatriptan. J Adv Pharm Technol Res. 2023;14(2):119.

Taher SS, Sadeq ZA, Al-Kinani KK, Alwan ZS. solid lipid nanoparticles as a promising approach for delivery of anticancer agents. Mil Med Sci Lett Zdr List. 2022;91(3).

Hussein LS, Al-Khedairy EB. Solubility and dissolution enhancement of ebastine by surface solid dispersion technique. Iraqi Journal of Pharmaceutical Sciences. 2021; 30(1):122-32.

Downloads

Published

2025-06-25

Issue

Vol. 34 No. 2 (2025): Iraqi J Pharm Sci

Section

Article

License

Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.